Dynavax Technologies Corporation (DVAX)

Exchange
NASDAQ
Symbol
DVAX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company is headquartered in Emeryville, California.
Country
USA

Stock price

At close: November 7, 2025

  • Open
    10.98
  • High
    11.06
  • Low
    10.52
  • Close
    10.83
  • Volume
    2,223,830

Financial ratios

Dec 31, 2024